Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.
作者： S. Jolles , J. S. Orange , A. Gardulf , M. R. Stein , R. Shapiro
DOI: 10.1111/CEI.12485
关键词:
摘要: Primary antibody deficiencies require lifelong replacement therapy with immunoglobulin (Ig)G to reduce the incidence and severity of infections. Both subcutaneous and intravenous …
oup.com
sci-hub.se 参考文章(87)
Chaim M Roifman, Harry Schroeder, Melvin Berger, Ricardo Sorensen, Mark Ballow, Rebecca H Buckley, Anita Gewurz, Phillip Korenblat, Gordon Sussman, Georg Lemm, IGIV-C in PID study group, Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency ☆: A randomized double-blind trial International Immunopharmacology. ,vol. 3, pp. 1325- 1333 ,(2003) , 10.1016/S1567-5769(03)00134-6
H Chapel, V Brennan, E Delson, Immunoglobulin replacement therapy by self-infusion at home. Clinical and Experimental Immunology. ,vol. 73, pp. 160- 162 ,(1988)
H. M. Chapel, G. P. Spickett, D. Ericson, W. Engl, M. M. Eibl, J. Bjorkander, The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. Journal of Clinical Immunology. ,vol. 20, pp. 94- 100 ,(2000) , 10.1023/A:1006678312925
H. Eijkhout, P.J.J.A. van den Broek, J.W.M. van der Meer, Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy Netherlands Journal of Medicine. ,vol. 61, pp. 213- 217 ,(2003)
Mark R. Stein, USE OF SUBCUTANEOUS IgG IN PATIENTS ON CONCOMITANT ANTICOAGULANT AND ANTIPLATELET THERAPY 2012 CIS Annual Meeting: Primary Immune Deficiency Disease North American Conference May 17 - 20, 2012. ,(2012)
A. Gardulf, E. Andersson, M. Lindqvist, S. Hansen, R. Gustafson, Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. Journal of Clinical Immunology. ,vol. 21, pp. 150- 154 ,(2001) , 10.1023/A:1011051704960
F Hoffmann, , B Grimbacher, J Thiel, HH Peter, BH Belohradsky, Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency European Journal of Medical Research. ,vol. 15, pp. 238- 245 ,(2010) , 10.1186/2047-783X-15-6-238
H. S. Hernandez-Trujillo, H. Chapel, V. Lo Re III, L. D. Notarangelo, B. Gathmann, B. Grimbacher, J. M. Boyle, V. P. Hernandez-Trujillo, C. Scalchunes, M. L. Boyle, J. S. Orange, Comparison of American and European practices in the management of patients with primary immunodeficiencies. Clinical and Experimental Immunology. ,vol. 169, pp. 57- 69 ,(2012) , 10.1111/J.1365-2249.2012.04588.X
A Martin, L Lavoie, M Goetghebeur, R Schellenberg, None, Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency. Transfusion Medicine. ,vol. 23, pp. 55- 60 ,(2013) , 10.1111/J.1365-3148.2012.01201.X
R. Shapiro, Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push Clinical and Experimental Immunology. ,vol. 173, pp. 365- 371 ,(2013) , 10.1111/CEI.12099